Expert Hematopathology Insight
In addition to detailed coverage of hematopoietic neoplasms, the Masters of Pathology Series — Hematopathology program covers selected topics in hemostasis, thrombosis, and red blood cell pathology commonly encountered in pathology practices. Designed for both the practicing pathologist and the pathologist in training, this CME course will help you to better:
– Use results of immunophenotypic, genetic, and molecular studies when diagnosing hematopoietic neoplasms
– Interpret the diagnostic tests used to evaluate hemoglobinopathy, thalassemia, and selected hemostasis disorders
– Understand practical aspects of new developments and updates as you prepare for exams or certification
CHECK SAMPLES
1. Hematopathology - Masters of Pathology Series
1
|
Acute Myeloid Leukemia – Sharad C. Mathur, MD |
2
|
Benign and Reactive Conditions of Lymph Nodes – Dennis P. O’Malley, MD |
3
|
Myeloproliferative Neoplasms – Sharad C. Mathur, MD |
4
|
Myelodysplastic Syndromes – Sharad C. Mathur, MD |
5
|
B-cell Neoplasms of Small Lymphocyte Size – Sharad C. Mathur, MD |
6
|
Aggressive B-cell Neoplasms – Dennis P. O’Malley, MD |
7
|
Hodgkin Lymphoma – Sharad C. Mathur, MD |
8
|
Immunosecretory Disorders – Sharad C. Mathur, MD |
9
|
Overview of T Cell Lymphomas – Dennis P. O’Malley, MD |
10
|
Lymphoblastic Leukemias, Lymphomas and Related Diseases – Dennis P. O’Malley, MD |
11
|
Overview of the Spleen – Dennis P. O’Malley, MD |
12
|
Hemoglobinopathies and Thalassemias – Sharad C. Mathur, MD |
13
|
Selected Topics in Hemostasis – Sharad C. Mathur, MD |
Learning Objectives
After viewing this program, participants should be able to:
– Describe the current WHO diagnostic criteria for the diagnosis of hematopoietic neoplasms
– Correctly utilize and interpret results of immunophenotypic, genetic, and molecular studies in the diagnosis and classification of hematopoietic neoplasms
– Summarize and correctly interpret diagnostic tests utilized in the evaluation of hemoglobinopathy, thalassemia, and selected disorders of hemostasis
Intended Audience
The program is designed both for practicing pathologists and for pathologists-in-training with emphasis on practical aspects of novel developments and updates for preparation for board examinations and maintenance of certification.
Designation
Date of Original Release: July 15, 2018
Date Credits Expire: July 15, 2021
Estimated Time to Complete: 11.5 hours